Notas del episodio
This week's sweep covers six items from the September Annals of Internal Medicine. It opens with EMPOWER, a randomized trial finding that adding CBT or peer-led self-management to a patient-centered opioid taper didn't improve success, though roughly half of patients halved their dose with a well-supported taper alone. Two obesity pieces follow — the ACP's living review of weight-loss drugs and the updated VA/DoD guideline — which converge on treating obesity as a chronic condition and not stopping effective medication. Two ACP Journal Club items show benefits that look better in the headline than the detail: a digoxin meta-analysis where fewer heart failure events carry the whole effect while cardiovascular death doesn't budge, and TAPIS, where early dual antiplatelet therapy after stroke thrombolysis improved function in a population too narrow to generalize. It closes with practical guidance on protecting immigrant patients, from documentation and health care proxies to rights in custody.